Fly News Breaks for January 23, 2020
Jan 23, 2020 | 14:39 EDT
Cowen analyst Joshua Jennings noted that Cerus highlighted several publications that have shown the Intercept Blood System to be an effective mitigation tool for inactivating members of the coronavirus family similar to the 2019 novel coronavirus that has emerged. The analyst, who said he is encouraged by the data and continues to view Intercept as "the premier platform to help secure the safety of the global blood supply," keeps an Outperform rating on Cerus shares.
News For CERS From the Last 2 Days
There are no results for your query CERS